Cargando…
Correction: Clinical impact of measurable residual disease monitoring by ultradeep next generation sequencing in NPM1 mutated acute myeloid leukemia
Autores principales: | Patkar, Nikhil, Kodgule, Rohan, Kakirde, Chinmayee, Raval, Goutham, Bhanshe, Prasanna, Joshi, Swapnali, Chaudhary, Shruti, Badrinath, Y., Ghoghale, Sitaram, Kadechkar, Shraddha, Khizer, Syed Hasan, Kannan, Sadhana, Shetty, Dhanalaxmi, Gokarn, Anant, Punatkar, Sachin, Jain, Hasmukh, Bagal, Bhausaheb, Menon, Hari, Sengar, Manju, Khattry, Navin, Tembhare, Prashant, Subramanian, Papagudi, Gujral, Sumeet |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6355171/ https://www.ncbi.nlm.nih.gov/pubmed/30728913 http://dx.doi.org/10.18632/oncotarget.26610 |
Ejemplares similares
-
Clinical impact of measurable residual disease monitoring by ultradeep next generation sequencing in NPM1 mutated acute myeloid leukemia
por: Patkar, Nikhil, et al.
Publicado: (2018) -
Utility of Immunophenotypic Measurable Residual Disease in Adult Acute Myeloid Leukemia—Real-World Context
por: Patkar, Nikhil, et al.
Publicado: (2019) -
Clinical impact of panel-based error-corrected next generation sequencing versus flow cytometry to detect measurable residual disease (MRD) in acute myeloid leukemia (AML)
por: Patkar, Nikhil, et al.
Publicado: (2021) -
A novel machine-learning-derived genetic score correlates with measurable residual disease and is highly predictive of outcome in acute myeloid leukemia with mutated NPM1
por: Patkar, Nikhil, et al.
Publicado: (2019) -
Machine learning derived genomics driven prognostication for acute myeloid leukemia with RUNX1-RUNX1T1
por: Shaikh, Anam Fatima, et al.
Publicado: (2020)